Icon plc Stock
Icon plc gained 0.160% compared to yesterday.
Icon plc is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 199 € shows a positive potential of 27.56% compared to the current price of 156.0 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | 0.160% | -3.141% | -1.982% | -26.775% | 0.516% | -23.652% | - |
| Alkermes plc | -0.790% | 5.000% | 4.132% | -8.029% | 6.780% | 3.725% | 50.898% |
| Novocure Ltd | -4.380% | 14.171% | 9.802% | -52.333% | 12.660% | -85.794% | -90.872% |
| Ironwood Pharmaceuticals | 1.740% | -7.182% | 7.006% | -23.636% | 26.316% | -68.356% | -65.361% |
Comments
Icon (NASDAQ:ICLR) was upgraded by analysts at Rothschild & Co Redburn from a "neutral" rating to a "buy" rating. They now have a $236.00 price target on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon (NASDAQ:ICLR) had its price target raised by analysts at Robert W. Baird from $222.00 to $224.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
Icon Plc (NASDAQ: ICLR) was upgraded by analysts at Baird R W from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for ICLR provided by MarketBeat
News
3 Healthcare Pathbreakers With Long-Term Tailwinds
In the world of healthcare stocks, a major innovation, new medical device, or successful drug treatment can cement a firm's position as a leader. Unfortunately, many firms chase after these goals
